L'échange gratuit au péril de la commercialisation = The free exchange in peril of commercial activitiesLEBEAU, A.Météorologie (Paris. 1925). 1995, Num 9, pp 71-83, issn 0026-1181Article

Determination of the structure of a synthetic impurity in guaifenesin: modification of a high-performance liquid chromatographic method for phenylephrine hydrochloride, phenylpropanolamine hydrochloride, guaifenesin, and sodium benzoate in dosage formsSCHIEFFER, G. W; SMITH, W. O; LUBEY, G. S et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 12, pp 1856-1858, issn 0022-3549Article

Isomeric purity and supersaturation of iopamidolDAWSON, P; PITFIELD, J; SKINNEMOEN, K et al.British journal of radiology. 1983, Vol 56, Num 670, pp 711-713, issn 0007-1285Article

Sparsame Modifikation des kommerziellen Ciclosporin-Radioimmunoassay = Modification économique de la ciclosporine commerciale dans des dosages radioimmunologiques = Economical modification of the commercialy available ciclosporine in radioimmunoassayLAMPE, D; PRÜMKE, H.-J; HÜLLER, H et al.Pharmazie. 1988, Vol 43, Num 1, issn 0031-7144, 4Article

Creating smaller eyedrops by reducing eyedropper tip dimensionsBROWN, R. H; HOTCHKISS, M. L; DAVIS, E. B et al.American journal of ophthalmology. 1985, Vol 99, Num 4, pp 460-464, issn 0002-9394Article

Commercial CAPTAIN systemISOZAKI, K.Japan Telecommunications Review. 1983, Vol 25, Num 4, pp 246-254, issn 0021-4744Article

Problems with generic theophylline and indiscriminate brand switchingKLEIN, G. L.Annals of allergy. 1987, Vol 58, Num 5, pp 350-352, issn 0003-4738Article

Allergenic extracts: characterization, standardization, and prospects for the futureYUNGINGER, J. W.The Pediatric clinics of North America. 1983, Vol 30, Num 5, pp 795-805, issn 0031-3955Article

Gas chromatography assay of atropine in formulations containing atropine sulphate and cholinesterase reactivatorsBRIGGS, C. J; SIMONS, K. J.Journal of chromatography. 1983, Vol 257, Num 1, pp 132-136, issn 0021-9673Article

The bioavailability of three dipyridamole productsMARKIEWICZ, A; HARTLEB, M; BOLDYS, H et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1983, Vol 21, Num 10, pp 499-501, issn 0174-4879Article

AESGP 19th annual meeting, Stockholm, June 8-10, 1983Association européenne des spécialités pharmaceutiques grand public. Annual meeting. 19. 1983, 36 p.Conference Proceedings

Nouveaux médicaments : Principes actifs entrant dans la composition de spécialités pharmaceutiques commercialisées en 1996 = A survey of some new drugsOSLET, J.Journal de pharmacie de Belgique. 1997, Vol 52, Num 1, pp 28-40, issn 0047-2166Article

Sorption und oxidative Veränderungen von 3-Butylhydroxyanisol (3-BHA) in SiO₂-Dispersionen. 2. Mitt: Stabilität von 3-BHA in Sorbaten handelsüblicher SiO₂-Präparate = Adsorption et oxydation du 3-BHA dans les dispersions de silice = Adsorption and oxidative alterations of 3-butylhydroxyanisole (3-BHA) in silica dispersionsTISCHINGER-WAGNER, H; RUPPRECHT, H.Pharmazeutische Industrie. 1984, Vol 46, Num 10, pp 1056-1062, issn 0031-711XArticle

Bioequivalence studies for veterinary drug productsRHODES, C. T.Clinical research and regulatory affairs. 1992, Vol 9, Num 1, pp 1-9Article

Fatty acid compositions of the lipids obtained from commercial salmon productsOTA, T; SASAKI, S; ABE, T et al.Nippon Suisan Gakkaishi. 1990, Vol 56, Num 2, pp 323-327, issn 0021-5392Article

Pyrethrin poisoning from commercial-strength flea and tick sprayPATON, D. L; WALKER, J. S.The American journal of emergency medicine. 1988, Vol 6, Num 3, pp 232-235, issn 0735-6757Article

On the contamination of commercially available aprotinins with pancreatic islet peptidesBALDISSERA, F. G. A; HOLST, J. J.Scandinavian journal of clinical & laboratory investigation. 1984, Vol 44, Num 7, pp 669-672, issn 0036-5513Article

Problems in the measurement of zinc using heparin as an anticoagulantGERVIN, C. A; GERVIN, A. S; NICHOLS, W et al.Life sciences (1973). 1983, Vol 33, Num 26, pp 2643-2649, issn 0024-3205Article

Confusion entre noms commerciaux : entretenue par les agences du médicament = Confusion between commercial names : maintained by drug agenciesLa Revue Prescrire. 2007, Vol 27, Num 290, pp 941-944, issn 0247-7750, 4 p.Article

Eigenschaften hineinkonstruiert = Preparation-integrated propertiesPlastverarbeiter. 1997, Vol 48, Num 9, pp 62-63, issn 0032-1338Article

DuPont Dow Elastomers enrichit sa gamme Viton = DuPont Dow Elastomers enlarges its Viton rangeCaoutchoucs & plastiques (Paris). 2001, Num 800, pp 54-56, issn 1154-1105Article

Flixotide : Generic Name : Fluticasone propionateMALLARKEY, G.Current therapeutics. 1996, Vol 37, Num 2, pp 65-66, issn 0311-905XArticle

Analysis of thianaphthene in commercial naphthaleneMCKAGUE, A. B; MEIER, H. P.Journal of chromatography. 1984, Vol 299, Num 2, pp 487-488, issn 0021-9673Article

Bioavailability of propylthiouracil in humansRINGHAND, H. P; RITSCHEL, W. A; MEYER, M. C et al.Journal of pharmaceutical sciences. 1983, Vol 72, Num 12, pp 1409-1412, issn 0022-3549Article

ANTIBODY RESPONSES IN MAN AFTER SINGLE OR REPEATED TREATMENT WITH INTRAMUSCULAR AMPICILLINAHLSTEDT S; HUITFELDT B; MAESEN F et al.1981; INT. ARCH. ALLERGY APPL. IMMUNOL.; ISSN 0020-5915; CHE; DA. 1981; VOL. 66; NO 4; PP. 382-390; BIBL. 22 REF.Article